The Health and Welfare Committee Of The National Assembly Visited Daewoong Pharmaceutical Hyangnam Factory

60 participants personally confirmed that it is a safe and reliable drug manufacturing place. 
Aiming at the world top factory through cutting-edge production system and thorough quality control

The members of the National Assembly who belong to the Health and Welfare Committee visited Daewoong Pharmaceutical Hyangnam Factory on Oct. 5^th to inspect the drug manufacturing facilities.


▲ The members of the National Assembly belonging to the Health and Welfare Committee visited Daewoong Pharmaceutical Hyangnam Factory in Hyangnam Pharmaceutical Complex located at Hyangnam-myeon, Hwaseong-si, Gyeonggi Province on 5^th p.m., and are listening to the explanation of drug manufacturing process from the person concerned.

This visit where 60 participants including Lee Seok Hyeon(The URI Party), Chairman of the committee, and the members, and persons concerned in the Korea Food & Drug Administration and Ministry of Health and Welfare was a part of inspection of the government offices by the Ministry of Health and Welfare to inspect the drug manufacturing field of domestic leading pharmaceutical companies.

This recent inspection in the middle of the current that more attention has been paid to drug safety with respect to national health was made by order of introduction of the factory by Lee Jin Ho, Chief of the Production Division and inspection of ▶ cutting-edge automated production lines ▶thorough and systematic QA system ▶unmanned automation warehouse securing the storing quality ▶ welfare facilities for employees including fitness club, golf course, audio-visual room and rest room.

The visitors gave confidence to the fact that the factory is keeping national health by producing valuable drugs under the world level of QA system and the strict manufacturing principle as a domestic leading drug manufacturer, and were highly satisfied with the clean and environment-friendly manufacturing and working environment.

“This inspection was an opportunity for us to confirm Daewoong’s systematic and full-scale effort to produce quality drugs and specially to recognize the importance of ‘safety’ and ‘reliance’ of the quality as drug manufacturer,” the visitors said. The person concerned in the factory said “We will be reborn to be world top drug manufacturing factory through more rigid QC and employees’ factory operation in fine feather beyond the current level.” The factory has obtained all international certifications of environment, health and safety including KGMP and KGSP, produced drugs by introducing the QC standard of cGMP levels for the first time in the industry, and is securing manufacturing competitiveness equivalent to the world-leading pharmaceutical companies in terms of the scale of single factory in domestic pharmaceutical industry.